Trends in US hospitalizations for anaphylaxis among infants and toddlers: 2006 to 2015

Lacey B Robinson1, Anna Chen Arroyo2, Mohammad Kamal Faridi3

  • 1Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Insights

US infant and toddler anaphylaxis hospitalizations remained stable from 2006-2015, unlike older children whose rates increased. Further research is needed on this young population.

Area of Science:

  • Pediatric Allergy and Immunology
  • Public Health Trends
  • Epidemiology

Background:

  • Anaphylaxis, a severe allergic reaction, has increasing prevalence.
  • US hospitalization trends for anaphylaxis in infants and toddlers are not well understood.

Purpose of the Study:

  • To analyze US hospitalization trends for anaphylaxis in young children (under 3 years).
  • To identify predictors of anaphylaxis hospitalizations in infants and toddlers.

Main Methods:

  • Analysis of the National Inpatient Sample (NIS) from 2006-2015.
  • Inclusion of patients with anaphylaxis using ICD-9-CM codes.
  • Multivariable logistic regression to identify predictors in infants and toddlers.

Main Results:

  • Anaphylaxis hospitalizations in infants and toddlers showed no significant trend (P=0.14).
  • Hospitalizations were more common in males, privately insured, higher income, with chronic pulmonary disease, and in urban Northeast teaching hospitals.
  • In contrast, anaphylaxis hospitalizations rose significantly in older children (3-18 years, P<0.001).

Conclusions:

  • US anaphylaxis hospitalizations for infants and toddlers were stable between 2006-2015.
  • Hospitalizations for older children increased during the same period.
  • Further research on disease prevalence and healthcare use in young children is recommended.
Abstract

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
31.4K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
139
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
168
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
145
Vaccinations01:51

Vaccinations

Overview
50.5K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.2K